Myriad Genetics
MYGN
MYGN
213 hedge funds and large institutions have $2.55B invested in Myriad Genetics in 2021 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 78 increasing their positions, 65 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
213
Holders Change
+12
Holders Change %
+5.97%
% of All Funds
3.74%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
27
Increased
78
Reduced
65
Closed
13
Calls
$7.61M
Puts
$4.29M
Net Calls
+$3.32M
Net Calls Change
+$1.96M
Top Buyers
Top Sellers
| 1 |
Two Sigma Advisers
New York
|
$4.12M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
$88.8M |
| 3 |
GCM
Glenview Capital Management
New York
|
$72.2M |
| 4 |
Millennium Management
New York
|
$21.3M |
| 5 |
D.E. Shaw & Co
New York
|
$64.9M |
